Phase I Study of In Vivo Expansion of Melan-A/MART-1 Antigen-Specific CD8 T Lymphocytes Following Transient Immunosuppression in Patients With Advanced Melanoma.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Immunotherapies; Melanoma vaccine
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 20 Nov 2012 Biomarkers information updated
- 29 Oct 2006 New trial record.